Filing Details

Accession Number:
0001140361-17-008415
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-21 17:45:20
Reporting Period:
2017-02-16
Filing Date:
2017-02-21
Accepted Time:
2017-02-21 17:45:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184157 T William End One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-16 5,000 $141.71 50,256 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the weighted average sales price of the shares sold ranging from a low of $141.6166 to a high of $141.8165 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.